Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell)
Clinical trial NCT05574985 · COMPLETED
Trial details
- NCT number
- NCT05574985
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-29
- Primary completion
- 2022-10-09
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.